Lung Stereotactic Radiation Therapy for Patients With Non-small Cell Lung Cancer and Other Cancers
The purpose of this institutional protocol is to offer SBRT to selected patients in a
controlled environment to refine treatment techniques (including dose/fractionation
schedules) and standardize follow-up. SBRT has been in clinical use for over a decade in
some institutions and the available data suggest that it can be used safely and with good
results. This study will see how effective Stereotactic Body Radiation Therapy is for
treating tumours in the lung and how often people have side effects. Radiation therapy is
usually given once a day, often for a few weeks. In this study, study participants will
receive high doses of radiation treatment to tumours in the lung for 3 to 10 treatment
sessions over a total of about 1 to 2 weeks.
Several reports indicate that this therapy might shrink tumours and control the cancer for
extended periods of time. Although specialists started to treat patients with SBRT over 10
years ago, it is still used in relatively few cancer centres.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society